Home › Funds › ANTIPODES PARTNERS Ltd › BKD

ANTIPODES PARTNERS Ltd position in BKD

BROOKDALE SR LIVING INC · Health Care

ANTIPODES PARTNERS Ltd reported holding 10,226,971 shares of BKD (BROOKDALE SR LIVING INC) in its Q3 2026 13F filing — a position valued at US$110.8M, representing 2.04% of its reported portfolio and ranking #20 among its reported holdings. ANTIPODES PARTNERS Ltd has disclosed BKD holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)10.23M sh
Reported value held$110.76M
Portfolio Weight2.04%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ANTIPODES PARTNERS Ltd's BKD position evolved

ANTIPODES PARTNERS Ltd first disclosed a stake in BKD in Q2 2024 at 14,670 shares (US$100K). The position peaked in Q2 2026 at 11,091,757 shares, worth US$178.5M. Across 10 filings, ANTIPODES PARTNERS Ltd increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 10,226,971 shares valued at US$110.8M — a reduction of -864,786 shares quarter over quarter.. Notable position changes include a 27529% increase in Q3 2024 (shares fell 26% over the following quarter), a 87% increase in Q4 2024 (shares rose 24% over the following quarter), a 81% increase in Q1 2025 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 14.67K $100.20K New
Q3 2024 4.05M $27.52M Add
Q4 2024 7.56M $38.03M Add
Q1 2025 13.68M $85.67M Add
Q2 2025 14.15M $98.50M Add
Q3 2025 12.10M $102.46M Reduce
Q4 2025 11.43M $123.33M Reduce
Q1 2026 11.41M $156.05M Hold
Q2 2026 11.09M $178.47M Reduce
Q3 2026 10.23M $110.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BKD and 13F data

BKD (BROOKDALE SR LIVING INC) is a Health Care company. 44 other funds we track also report a position in BKD — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$187.2M), Maple Rock Capital Partners Inc. (US$143.0M), Luxor Capital Group, LP (US$59.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BKD

All BKD fund holders →

FAQ

How long has ANTIPODES PARTNERS Ltd held BKD?

ANTIPODES PARTNERS Ltd has disclosed BKD holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is ANTIPODES PARTNERS Ltd's current position in BKD?

As of Q3 2026, ANTIPODES PARTNERS Ltd holds 10.23M shares of BKD (BROOKDALE SR LIVING INC), valued at $110.76M, representing 2.04% of its reported portfolio and ranking #20.

Has ANTIPODES PARTNERS Ltd been buying or selling BKD?

In the latest 13F filing (Q3 2026), ANTIPODES PARTNERS Ltd reduced its position in BKD. The position peaked in Q2 2026 at 11.09M shares.

Which other funds hold BKD?

Other major institutional holders of BKD include DEERFIELD MANAGEMENT COMPANY, L.P., Maple Rock Capital Partners Inc., Luxor Capital Group, LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.